University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 2 of 9
Hybrid Type 1 Randomized Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families
NCT06261463
Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
NCT06410261
Self-Adhering Magnetic Device to Treat Corneal Exposure
NCT06291818
Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss
NCT05929508
School-based Support for Pre-school Aged Children With Developmental Disabilities and Delays
NCT06145659
Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
NCT06223165
The REACTplusNMES Trial: A Double-blinded RCT
NCT06127602
Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis
NCT06264336
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors
NCT06504914
Prostate Single Port & Laser Enucleation Comparison Trial
NCT06224218
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
NCT06169371
BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer
NCT06085742
Executive Function and Parenting in Childhood
NCT06241300
Study of Mental Health and Relationships
NCT06534827
Pilot Testing of a Structural Racism Intervention for Immigrant Latinx Families
NCT05991739
MindWalk Intervention for Older South Asian Caregivers of People With Cognitive Disabilities (CD)
NCT06002919
Resilience in East Asian Immigrants for Advance Care Planning Discussions
NCT06035549
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
NCT06206486
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
NCT05705024
StuDy AimED at Increasing AlCohol AbsTinEnce
NCT05778734
Enhancing Immune Health Randomized Controlled Trial
NCT05639881
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
NCT05051618
Improving the Health and Social Participation of People With Disabilities From Underrepresented Groups Post COVID
NCT05792852
MADRE (Mammograms Available Due to Research and Education)
NCT05841355
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
NCT04518657
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
NCT05483283
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
NCT05344833
A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)
NCT05613413
Home-based FES Training in People With Chronic Stroke
NCT05849532
Optimizing Orthodontic Appliances Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms
NCT05573308
Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.
NCT05516537
Better Lifestyle Counseling for African American Women During Pregnancy
NCT05234125
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
NCT05664867
Time Restricted Eating During Chemotherapy for Breast Cancer
NCT05259410
BUILT Family Lifestyle Program for Children with ADHD
NCT05464056
Multivariable Artificial Pancreas: Detecting and Mitigating Unannounced Physical Activity and Acute Psychological Stress
NCT05145374
Healthy ReStart Intervention to Improve Health and Functioning
NCT05544344
Melanated Group Midwifery Care (MGMC)
NCT05365815
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
NCT05114798
Role of Adiposomes in Endothelial Dysfunction
NCT05199454
Perioperative Nutritional Optimization in Head and Neck Cancer Patients
NCT04449445
Utilization of a Videoscope in Periodontal Regeneration
NCT05275192
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
NCT05294042
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
NCT04753359
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
NCT04891068
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
NCT05192122
Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans
NCT05094297
Dual Task Perturbation Training for OAwMCI
NCT04938349
Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
NCT04717427
Effect of NMES on Balance and Fall Risk in Chronic Stroke
NCT04957355
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets.Report a data error.